Lipid lowering interventions in genetic hyperlipidemia: Effects on lipoprotein metabolism and endothelial function

被引：0
|
作者：
de Bruin, TWA [1 ]
机构：
[1] Maastricht Univ, Cardiol Res Inst Maastricht, Dept Med & Endocrinol, Maastricht, Netherlands
来源：
JOURNAL OF VASCULAR RESEARCH | 1999年 / 36卷 / 02期
关键词：
D O I：
暂无
中图分类号：
Q4 [生理学];
学科分类号：
071003 ;
摘要：
引用
收藏
页码：155 / 155
页数：1
相关论文
共 50 条
  • [31] Genetic effects on efficacy of lipid-lowering drugs
    Brown, William Virgil
    Brown, Alan S.
    Ference, Brian A.
    Toth, Peter P.
    Underberg, James A.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2017, 11 (05) : 1112 - 1117
  • [32] Importance of endothelial function in mediating the benefits at lipid-lowering therapy
    Brown, BG
    Zhao, XQ
    AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (10B): : 49T - 52T
  • [33] Simvastatin preserves coronary endothelial function in hypercholesterolemia in the absence of lipid lowering
    Wilson, SH
    Simari, RD
    Best, PJM
    Peterson, TE
    Lerman, LO
    Aviram, M
    Nath, KA
    Holmes, DR
    Lerman, A
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (01) : 122 - 128
  • [34] Effects of CETP inhibition on endothelial function in type II hyperlipidemia
    Hermann, F.
    Spieker, L. E.
    Sudano, I.
    Ruschitzka, F.
    Corti, R.
    Noll, G.
    Luescher, T. F.
    EUROPEAN HEART JOURNAL, 2006, 27 : 880 - 880
  • [35] Effects of lipid-lowering therapy with fibrates on endothelial function in patients with type 2 diabetes mellitus
    Watanabe, H
    Nakagawa, K
    Kakihana, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 210A - 210A
  • [36] EFFECTS OF ACTIVATION ON LIPID AND LIPOPROTEIN METABOLISM IN MURINE MACROPHAGES
    KRAEMER, FB
    TAVANGAR, K
    GANDJEI, RK
    KIRLEW, K
    BEHR, SR
    ARTERIOSCLEROSIS, 1990, 10 (01): : 8 - 16
  • [37] Effects of lipid-lowering drugs on ambulatory blood pressure in hypertensive patients with hyperlipidemia
    Kawano, Y
    Okuda, N
    Makino, Y
    Takishita, S
    JOURNAL OF HYPERTENSION, 2000, 18 : S146 - S146
  • [38] Effects of evolving lipid-lowering drugs on carbohydrate metabolism
    Tsimihodimos, V.
    Elisaf, M.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 137 : 1 - 9
  • [39] Lipid-lowering therapy with fluvastatin inhibits oxidative modification of low density lipoprotein and improves vascular endothelial function in hypercholesterolemic patients
    Inoue, T
    Hayashi, M
    Takayanagi, K
    Morooka, S
    ATHEROSCLEROSIS, 2002, 160 (02) : 369 - 376
  • [40] ENDOTHELIAL DYSFUNCTION AND DYSLIPIDEMIA - POSSIBLE EFFECTS OF LIPID-LOWERING AND LIPID MODIFYING THERAPY
    VANBOVEN, AJ
    JUKEMA, JW
    PAOLETTI, R
    PHARMACOLOGICAL RESEARCH, 1994, 29 (03) : 261 - 272
12345